TCL Archive NCAB Urges Reprogramming If Needed To Assure $150 Million For Construction Through FY 1985 June 8, 1979
TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002